Related Experiment Video
Updated: Jul 20, 2026
04:50
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Methotrexate in rheumatoid arthritis
Jerzy Swierkot1, Jacek Szechiński
1Department of Rheumatology, Medical University of Wrocław, Wiśniowa 36, PL 51-137 Wrocław, Poland. jurekswierkot0@poczta.onet.pl
Pharmacological Reports : PR
|September 12, 2006
Summary
Methotrexate (MTX) is a widely used disease-modifying antirheumatic drug (DMARD) for rheumatoid arthritis (RA). While effective and well-tolerated, some patients require combination therapy for optimal disease control.
Area of Science:
- Rheumatology
- Pharmacology
Background:
- Rheumatoid arthritis (RA) management relies on disease-modifying antirheumatic drugs (DMARDs).
- Methotrexate (MTX) is the most frequently prescribed DMARD globally for RA patients.
- The precise anti-inflammatory mechanism of low-dose MTX in RA remains unclear.
Purpose of the Study:
- To review the role and efficacy of Methotrexate (MTX) in rheumatoid arthritis (RA) treatment.
- To assess the current standing of MTX in RA therapy, including its combinations with other agents.
Main Methods:
- Review of existing meta-analyses and clinical data on MTX in RA.
- Analysis of MTX efficacy, toxicity, and therapeutic monitoring.
Main Results:
- MTX demonstrates a favorable efficacy/toxicity ratio, making it a first-line RA treatment.
- Therapeutic drug monitoring of MTX concentration does not significantly impact treatment effectiveness.
- A substantial proportion of RA patients on MTX monotherapy do not achieve optimal disease control.
Conclusions:
- MTX remains a cornerstone therapy for rheumatoid arthritis.
- Combination therapies involving MTX with conventional DMARDs or biological agents are crucial for improving outcomes.
- The goal of RA treatment is to balance therapeutic benefits against risks, aiming for remission and reduced disability.
Related Concept Videos
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...